Cargando…
Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
Proteinuria, in particular albuminuria, is a potentially significant modifiable risk factor for cardiovascular disease and the progression of kidney disease. Current treatment guidelines for albuminuria recommend a single renin–angiotensin–aldosterone inhibitor. This can be an ACE inhibitor or an an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
NPS MedicineWise
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450775/ https://www.ncbi.nlm.nih.gov/pubmed/32921887 http://dx.doi.org/10.18773/austprescr.2020.021 |